USNA trades 156.8% below Wall Street's consensus target of $35.00.
Last 12 months price action with 12-month analyst target path
The base valuation assumes USNA achieves its forward estimates and maintains a stable P/E multiple of 7.8x. This scenario reflects the blended consensus of 8 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of November 8, 2026, USANA Health Sciences, Inc. (USNA) has a Wall Street consensus price target of $35.00, based on estimates from 8 covering analysts. With the stock currently trading at $13.63, this represents a potential upside of +156.8%. The company has a market capitalization of $252M.
Analyst price targets range from a low of $35.00 to a high of $35.00, representing a 0% spread in expectations. The median target of $35.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Hold, with 2 analysts rating the stock as a Buy or Strong Buy,5 rating it Hold, and 1 rating it Sell or Strong Sell. The bearish sentiment suggests caution about the stock at current levels.
From a valuation perspective, USNA trades at a trailing P/E of -11.9x and forward P/E of 7.8x. Analysts expect EPS to grow +245.1% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $1.83, with bear and bull scenarios of $1.15 and $2.41 respectively. Model confidence stands at 40/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 NUSNu Skin Enterprises, Inc. | $199M | $4.10 | $11.00 | +168.3% | Hold | 5.0x | 11 |
 NATRNature's Sunshine Products, Inc. | $191M | $10.87 | $31.00 | +185.2% | Buy | 10.3x | 4 |
 NHTCNatural Health Trends Corp. | $8M | $0.77 | — | — | — | — | — |
 HLFHerbalife Nutrition Ltd. | $1.6B | $15.28 | $21.00 | +37.4% | Buy | 6.3x | 26 |
 PLBYPlayboy, Inc. | $150M | $1.29 | $12.63 | +879.1% | Buy | — | 8 |
 CVSACovista Inc. | $3.7B | $110.32 | $92.86 | -27.6% | Buy | 15.9x | 3 |
 MGPIMGP Ingredients, Inc. | $364M | $16.98 | $25.50 | +50.2% | Buy | 10.2x | 10 |
 VITLVital Farms, Inc. | $408M | $9.52 | $11.50 | +20.8% | Buy | — | 16 |
 AMZNAmazon.com, Inc. | $2.8T | $259.30 | $328.48 | +26.7% | Buy | 20.2x | 96 |
 INGRIngredion Incorporated | $5.8B | $91.72 | $109.50 | +19.4% | Hold | 8.8x | 21 |
Quick answers to the most common questions about buying USNA stock.
The consensus Wall Street price target for USNA is $35, representing 156.8% upside from the current price of $13.63. With 8 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
USNA has a consensus rating of "Hold" based on 8 Wall Street analysts. The rating breakdown is mixed, with 5 Hold ratings making up the largest segment. The consensus 12-month price target of $35 implies 156.8% upside from current levels.
With a forward P/E of 7.8333x, USNA trades at a relatively low valuation. The consensus target of $35 implies 156.8% appreciation, suggesting meaningful undervaluation.
The most bullish Wall Street analyst has a price target of $35 for USNA, while the most conservative target is $35. The consensus of $35 represents the median expectation. Our quantitative valuation model projects a bull case target of $2 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
USNA is moderately covered, with 8 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 2 have Buy ratings, 5 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month USNA stock forecast based on 8 Wall Street analysts shows a consensus price target of $35, with estimates ranging from $35 (bear case) to $35 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $2, with bear/bull scenarios of $1/$2.
Our quantitative valuation model calculates USNA's fair value at $2 (base case), with a bear case of $1 and bull case of $2. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 40/100.
USNA trades at a forward P/E ratio of 7.8x based on next-twelve-months earnings estimates. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on USNA, with a "Hold" consensus rating and $35 price target (156.8% upside). 2 of 8 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
USNA analyst price targets range from $35 to $35, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $35 consensus represents the middle ground. Our model's $1-$2 range provides an independent fundamental perspective.
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.